{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:28:35Z","timestamp":1768703315088,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["brainstimjrnl.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Stimulation"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.brs.2022.08.012","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T23:41:10Z","timestamp":1661298070000},"page":"1184-1191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of medications, mood state, and electrode placement on ECT outcomes in treatment-refractory psychosis"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-2336","authenticated-orcid":false,"given":"Nicholas J.","family":"Ainsworth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Michelle","family":"Avina-Galindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall F.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denghuang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth C.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William G.","family":"Honer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8273-8820","authenticated-orcid":false,"given":"Fidel","family":"Vila-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.brs.2022.08.012_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v . first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.brs.2022.08.012_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1176\/appi.ajp.2015.15030332","article-title":"Comparative effectiveness of clozapine and standard antipsychotic treatment in adults with schizophrenia","volume":"173","author":"Stroup","year":"2016","journal-title":"Am J Psychiatr"},{"issue":"9","key":"10.1016\/j.brs.2022.08.012_bib3","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"1","author":"Howes","year":"2016","journal-title":"Am J Psychiatr"},{"issue":"8","key":"10.1016\/j.brs.2022.08.012_bib4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0004867418772351","article-title":"Augmentation strategies for clozapine refractory schizophrenia: a systematic review and meta-analysis","volume":"52","author":"Siskind","year":"2018","journal-title":"Aust N Z J Psychiatr"},{"issue":"5","key":"10.1016\/j.brs.2022.08.012_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/schbul\/sbr004","article-title":"Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review","volume":"38","author":"Sommer","year":"2012","journal-title":"Schizophr Bull"},{"issue":"14","key":"10.1016\/j.brs.2022.08.012_bib6","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00213-017-4616-7","article-title":"Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis","volume":"234","author":"Kishi","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.brs.2022.08.012_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1192\/bjp.bp.109.067710","article-title":"Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis","volume":"197","author":"Singh","year":"2010","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.brs.2022.08.012_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/appi.ajp.162.2.388","article-title":"Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia","volume":"162","author":"Bodkin","year":"2005","journal-title":"Am J Psychiatr"},{"issue":"1\u20132","key":"10.1016\/j.brs.2022.08.012_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.psychres.2014.04.006","article-title":"The prognostic significance of early remission of positive symptoms in first treated psychosis","volume":"218","author":"Norman","year":"2014","journal-title":"Psychiatr Res"},{"issue":"1\u20133","key":"10.1016\/j.brs.2022.08.012_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.schres.2016.01.024","article-title":"Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: a systematic review and meta-analysis","volume":"171","author":"Lally","year":"2016","journal-title":"Schizophr Res"},{"issue":"11","key":"10.1016\/j.brs.2022.08.012_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00429","article-title":"Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: a comparative meta-analysis","volume":"3","author":"Ahmed","year":"2017","journal-title":"Heliyon"},{"issue":"August","key":"10.1016\/j.brs.2022.08.012_bib12","first-page":"23","article-title":"Electroconvulsive therapy for negative symptoms in schizophrenia: a literature review from 2000 to 2021","volume":"105","author":"Zierhut","year":"2021","journal-title":"Curr Psychol"},{"issue":"4","key":"10.1016\/j.brs.2022.08.012_bib13","first-page":"244","article-title":"ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE","volume":"17","author":"Petrides","year":"2001","journal-title":"J\u00a0ECT"},{"key":"10.1016\/j.brs.2022.08.012_bib14","article-title":"Electroconvulsive therapy for schizophrenia","volume":"2","author":"Tharyan","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.brs.2022.08.012_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/08039488.2021.1877349","article-title":"Comparative study of effectiveness of augmentation with ECT in clozapine resistant schizophrenia (CRS) and non-clozapine resistant schizophrenia (Non-CRS)","volume":"6","author":"Grover","year":"2021","journal-title":"Nord J Psychiatr"},{"key":"10.1016\/j.brs.2022.08.012_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011847.pub2","article-title":"Electroconvulsive therapy for treatment-resistant schizophrenia (Review)","author":"Sinclair","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"10.1016\/j.brs.2022.08.012_bib17","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson's disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.brs.2022.08.012_bib18","first-page":"527","article-title":"Psychosis and schizophrenia in adults : prevention and management (NICE clinical guideline, CG178)","volume":"62","year":"2020","journal-title":"J\u00a0Clin Psychiatr"},{"key":"10.1016\/j.brs.2022.08.012_bib19","series-title":"The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia","year":"2020"},{"issue":"2","key":"10.1016\/j.brs.2022.08.012_bib20","first-page":"75","article-title":"The FDA and ECT","volume":"32","author":"McDonald","year":"2016","journal-title":"J\u00a0ECT"},{"issue":"2","key":"10.1016\/j.brs.2022.08.012_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brs.2012.04.002","article-title":"Double-blind randomized controlled study showing symptomatic and cognitive superiority of bifrontal over bitemporal electrode placement during electroconvulsive therapy for schizophrenia","volume":"6","author":"Phutane","year":"2013","journal-title":"Brain Stimul"},{"issue":"4","key":"10.1016\/j.brs.2022.08.012_bib22","first-page":"223","article-title":"ECT and clozapine in schizophrenia","volume":"14","author":"Fink","year":"1998","journal-title":"J\u00a0ECT"},{"key":"10.1016\/j.brs.2022.08.012_bib23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0163-8343(96)87727-9","article-title":"ECT-valproic acid interaction","volume":"17","author":"Pearlman","year":"1995","journal-title":"Gen Hosp Psychiatr"},{"issue":"9","key":"10.1016\/j.brs.2022.08.012_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0706743717720448","article-title":"Guidelines for the pharmacotherapy of schizophrenia in adults","volume":"62","author":"Remington","year":"2017","journal-title":"Can J Psychiatr"},{"issue":"4","key":"10.1016\/j.brs.2022.08.012_bib25","first-page":"361","article-title":"Electrical dose and seizure threshold: relations to clinical outcome and cognitive effects in bifrontal, bitemporal, and right unilateral ECT","volume":"16","author":"Delva","year":"2000","journal-title":"J\u00a0ECT"},{"issue":"2","key":"10.1016\/j.brs.2022.08.012_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0033291700017645","article-title":"Electrode placement in ECT: cognitive effects","volume":"20","author":"Lawson","year":"1990","journal-title":"Psychol Med"},{"key":"10.1016\/j.brs.2022.08.012_bib27","doi-asserted-by":"crossref","unstructured":"Letemendia FJ. Therapeutic advantage of bifrontal electrode placement in ECT. Psychol Med. 5AD;23(2):349\u2013360.","DOI":"10.1017\/S0033291700028452"},{"issue":"570","key":"10.1016\/j.brs.2022.08.012_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1192\/bjp.122.5.587","article-title":"Anterior bifrontal ECT: a clinical trial","volume":"122","author":"Abrams","year":"1973","journal-title":"Br J Psychiatry"},{"issue":"6","key":"10.1016\/j.brs.2022.08.012_bib29","first-page":"1847","article-title":"Comparison of the defined daily dose and chlorpromazine equivalent methods in antipsychotic drug utilization in six asian countries","volume":"8","author":"Lin","year":"2018","journal-title":"Neuropsychiatry"},{"key":"10.1016\/j.brs.2022.08.012_bib30","series-title":"The Jamovi Project","year":"2021"},{"issue":"10","key":"10.1016\/j.brs.2022.08.012_bib31","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.14r09528","article-title":"Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors","volume":"76","author":"Haq","year":"2015","journal-title":"J\u00a0Clin Psychiatr"},{"key":"10.1016\/j.brs.2022.08.012_bib32","series-title":"Treatment resistance in schizophrenia","first-page":"22","article-title":"A\u00a0systematic approach to treatment resistance in schizophrenic disorders","author":"May","year":"1988"},{"issue":"8","key":"10.1016\/j.brs.2022.08.012_bib33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.30773\/pi.2018.05.15","article-title":"Combination of electroconvulsive therapy and clozapine in treatment-resistant schizophrenia","volume":"15","author":"Kim","year":"2018","journal-title":"Psychiatry Investig"},{"issue":"9","key":"10.1016\/j.brs.2022.08.012_bib34","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/17512433.2016.1200971","article-title":"Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia","volume":"9","author":"Arumugham","year":"2016","journal-title":"Expet Rev Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.brs.2022.08.012_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004850-199903000-00002","article-title":"Elective combined electroconvulsive and clozapine therapy","volume":"14","author":"James","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.brs.2022.08.012_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1176\/appi.ajp.2014.13060787","article-title":"Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study","volume":"172","author":"Petrides","year":"2015","journal-title":"Am J Psychiatr"},{"issue":"5","key":"10.1016\/j.brs.2022.08.012_bib37","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/acps.12873","article-title":"The relationship between negative symptoms and depression in schizophrenia: a systematic review","volume":"137","author":"Krynicki","year":"2018","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"10.1016\/j.brs.2022.08.012_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1176\/ajp.157.1.121","article-title":"Comparison of bifrontal and bitemporal ECT for major depression","volume":"157","author":"Bailine","year":"2000","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.brs.2022.08.012_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1192\/apt.6.3.161","article-title":"Cognitive impairment in schizophrenia","volume":"6","author":"O'Carroll","year":"2000","journal-title":"Adv Psychiatr Treat"}],"container-title":["Brain Stimulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X22001905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X22001905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:24:09Z","timestamp":1761834249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1935861X22001905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1935861X22001905"],"URL":"https:\/\/doi.org\/10.1016\/j.brs.2022.08.012","relation":{},"ISSN":["1935-861X"],"issn-type":[{"value":"1935-861X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of medications, mood state, and electrode placement on ECT outcomes in treatment-refractory psychosis","name":"articletitle","label":"Article Title"},{"value":"Brain Stimulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brs.2022.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}